Eidos Therapeutics

YTD

ALL

Why Robinhood?

You can watch EIDX and buy or sell other stocks, ETFs, and their options commission-free!

About EIDX

BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source.

CEO

Neil Kumar, PhD

CEONeil Kumar, PhD

Employees

—

Employees—

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2013

Founded2013

Employees

—

Employees—

EIDX Key Statistics

Market cap

4.75B

Market cap4.75B

Price-Earnings ratio

-46.10

Price-Earnings ratio-46.10

Dividend yield

—

Dividend yield—

Average volume

138.46K

Average volume138.46K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$132.54

52 Week high$132.54

52 Week low

$28.39

52 Week low$28.39